Shares of Brenntag AG (OTCMKTS:BNTGY – Get Free Report) have been assigned a consensus recommendation of “Reduce” from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation and seven have given a hold recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $12.80.
Several brokerages have issued reports on BNTGY. Morgan Stanley reaffirmed an “underweight” rating on shares of Brenntag in a research note on Friday, May 15th. UBS Group upgraded shares of Brenntag from a “sell” rating to a “neutral” rating in a research report on Thursday, April 30th. Jefferies Financial Group raised shares of Brenntag from a “moderate sell” rating to a “hold” rating in a research note on Wednesday, May 20th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Brenntag from a “buy” rating to a “hold” rating in a research report on Tuesday, June 16th.
Read Our Latest Stock Analysis on Brenntag
Brenntag Price Performance
Brenntag (OTCMKTS:BNTGY – Get Free Report) last issued its quarterly earnings results on Wednesday, May 13th. The company reported $0.16 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.02). Brenntag had a return on equity of 5.28% and a net margin of 1.55%.The firm had revenue of $4.29 billion for the quarter, compared to analysts’ expectations of $4.33 billion. On average, equities research analysts anticipate that Brenntag will post 0.8 EPS for the current fiscal year.
About Brenntag
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
Featured Articles
- Five stocks we like better than Brenntag
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.
